Tamim S. Hamid Chief Executive Officer and President
	Tamim is an experienced leader with over 20 years focused on medical devices. Prior to starting Presym, Tamim was head of Business and Technology for Sanmina Medical Division, a $13 Billion NASDAQ-listed company.  Tamim also served in senior executive rolls at two start-ups with successful exits. His formative years were at Kennedy Space Center managing advanced research and development projects for NASA.
	David R. Hathaway Chief Medical Officer
	David brings expertise with clinical medicine and clinical trials, drug discovery, and medical devices. David was CMO for several start-up companies, including Arginox Pharmaceuticals, Restoragen, and Knoll Pharmaceutical. David served as VP, Cardiovascular Drug Recovery, for Bristol-Meyers Squibb. He is an inventor of the Perclose wound closure device and holds 12 patents.
	Colin Jacobs Legal, Commercial and Licensing
	Colin brings over 18 years of international experience in commercial and contract negotiations focused on Information Technology and health, with a specialization in risk mitigation. His assignments have covered the globe: from the U.S., U.K, New Zealand, Australia, Asia and Western Europe. Colin has led over 200 complex, high value transactions.
	Kanwar Kang Strategic Marketing
	Kanwar brings over 18 years of medical device experience to Presym. Prior to joining Presym in 2006, Kanwar was Senior Director, Strategy & Business Development for Philips Medical Systems. Prior to Philips, Kanwar held various management positions for 12 years with GE Medical Systems, focusing on digital X-rays and neuro-vascular products.
	Roman Shklanka Ph.D. Non-Executive Director
	Dr. Shklanka has over 40 years of experience in the mining industry. He worked for the Placer organization and was responsible for the acquisition of Tanzanian gold deposits which led to the sale of Sutton Resources for CAD$525 million in 1999. Most recently, Dr Shklanka was the Chairman of Canico Resource Corp which was purchased by CVRD for over CAD$865 million.

Copyright to Presym 2006